HFSA Annual Scientific Meeting 2022

September 30, 2022 - October 3, 2022 | Gaylord National Harbor | Washington, DC

Clinical Trial Central

HFSA Annual Scientific Meeting 2022 Banner Graphic

Clinical Trial Central provides a research-focused opportunity at HFSA Annual Scientific Meeting to share information through an electronic poster (ePoster) on:

  1. Trial in the recruitment or follow-up phase.
  2. How to get involved in company-supported research.

ASM's Clinical Trial Central is right for you if you are conducting a randomized trial, registry or first-in-man experiences with novel devices or drugs and are seeking participants to enroll patients in your trial or you want to share your trial data with colleagues and peers.

  • Submission Portal Opens: June 1, 2022
  • Submission Deadline: July 22, 2022
Submission Process

If your Clinical Trial Central submission has been approved, please review the 2022 Clinical Trial Central Instructions and Guidelines.

IMPORTANT INFORMATION: Authors and co-authors will need to submit disclosures in the portal by the submission deadline of July 22, 2022, 11:59 PM ET. Submissions with incomplete disclosures will not be considered.

Cost and Payment:

  • Industry Submissions: $999
  • Non-Profit Submissions: $999
  • NIH-Funded Submissions: Complimentary

You will submit payment at time of submission, through the submission portal. The fee for NIH-Funded Submissions is waived, and you will enter a code instead.

Why Submit Your Trial?

ASM's Clinical Trial Central can help you gain publicity:

  • All Clinical Trial Central ePosters received by the deadline will be listed in the HFSA Annual Scientific Meeting virtual meeting platform.
     
  • All Clinical Trial Central ePosters received by the deadline will be available for on-site viewing in the HFSA Annual Scientific Meeting Exhibit Hall.
     
  • Clinical Trial Central information received by the deadline will be listed in the Annual Scientific Meeting Digital Program Book.
     
  • Clinical Trial Central information will be included in email announcements to pre-registrants regarding exhibit hall activities.

All other rules for exhibiting apply. If you have questions for exhibiting, email lbest@gmimeetings.com. If you have questions for the submissions process, email aleong@hfsa.org.

 

Preparing Your ePoster

If Your Clinical Trial Central submission has been approved, please review the 2022 Clinical Trial Central Instructions and Guidelines.

Attendees - Why Visit Clinical Trial Central?

You will want to visit Clinical Trial Central to:

  • Find intriguing randomized trials, registries or first-in-man experiences with novel devices or drugs that may help your patients.
     
  • Explore the research that is being conducted via clinical trials and registries to learn what is on the horizon for novel therapies and drugs for the treatment of patients living with heart failure.
     
  • Select a randomized trial, registry, or patient trials for novel devices and drugs for which you can enroll patients in the interest of improving patient care and advancing the field.
     
  • Speak with a Clinical Trial Representative and ask your questions directly during the ePoster viewing sessions.